目的:研究过去三十年来泌尿生殖系统(GU)肿瘤学学术出版物中的性别差异。
方法:我们对八种学术期刊进行了文献计量学分析,其中包括GU肿瘤学研究文章:临床肿瘤学杂志,癌症,欧洲癌症杂志,欧洲泌尿外科,泌尿外科杂志,BJU国际,前列腺癌和前列腺疾病,泌尿外科肿瘤学:研讨会和原始调查。在选择四个时间点(1990年、2000年、2010年、2020年)后,我们记录了第一作者和资深作者的性别,并调查了他们与独立变量(包括出版年份)的关系,研究领域,地理大陆。结果表示为比值比(OR)和95%置信区间(CI)。
结果:总共14,786篇文章被纳入我们的分析。女性占第一作者的25.7%和高级作者的18.1%。与1990年相比,女性第一作者(2000年OR1.47[95%CI1.27-1.69];2010年2.28[95%CI2.00-2.59];2020年3.10[95%CI2.71-3.55])和高级作者职位(2000年OR1.23[95%CI1.05-1.45];2010年1.67[95%CI1.45-1.93];2020年2.55%CI20。与GU肿瘤学相比,非GU肿瘤文章更有可能是女性第一作者(OR2.61,95%CI2.38-2.86)或资深作者(OR2.61,95%CI2.35-2.91).来自亚洲的文章(OR0.45,95%CI0.38-0.51),非洲(OR0.45,95%CI0.22-0.91),与北美相比,国际合作(OR0.62,95%CI0.50-0.76)的女性第一作者比例较低.当资深作者也是女性时,第一作者更有可能是女性(OR2.45,95%CI2.23-2.69)。
结论:尽管显示了桥接趋势,GU肿瘤学仍然是男性主导的学科。女性领导和指导对于在学术医学界实现性别均等至关重要。
To examine gender disparities in genitourinary (GU) oncology academic publishing over the past three decades.
We performed a bibliometric analysis of eight academic journals featuring GU oncology research articles: Journal of Clinical Oncology, Cancer, European Journal of Cancer, European Urology, Journal of Urology, BJU International, Prostate Cancer and Prostatic Diseases, and Urologic Oncology: Seminars and Original Investigations. After selecting four time points (1990, 2000, 2010, 2020), we recorded the gender of the first and senior authors and investigated their association with independent variables including publication year, research field, and geographic continent. Results were expressed as odds ratios (ORs) and 95% confidence intervals (CIs).
A total of 14,786 articles were included in our analyses. Females comprised 25.7% of first and 18.1% of senior authors. Compared to 1990, there was a trend of progressively higher female first author (OR 1.47 [95% CI 1.27-1.69] in 2000; 2.28 [95% CI 2.00-2.59] in 2010; 3.10 [95% CI 2.71-3.55] in 2020) and senior author positions (OR 1.23 [95% CI 1.05-1.45] in 2000; 1.67 [95% CI 1.45-1.93] in 2010; 2.55 [95% CI 2.20-2.96] in 2020). Compared to GU oncology, non-GU oncology articles were more likely to have female first (OR 2.61, 95% CI 2.38-2.86) or senior authors (OR 2.61, 95% CI 2.35-2.91). Articles from Asia (OR 0.45, 95% CI 0.38-0.51), Africa (OR 0.45, 95% CI 0.22-0.91), and international collaborations (OR 0.62, 95% CI 0.50-0.76) had a lower proportion of female first authors compared to North America. First authors were significantly more likely to be female when senior authors were also female (OR 2.45, 95% CI 2.23-2.69).
Despite the bridging trend demonstrated, GU oncology remains a male-predominant discipline. Female leadership and mentorship are pivotal in achieving gender parity in the academic medicine community.